Skip to main content
. 2022 Jun 10;9:902171. doi: 10.3389/fmed.2022.902171

Table 2.

Comparison of characteristics between central and peripheral calciphylaxis patients.

Characteristic Total (N = 48) Central calciphylaxis (N = 20) Peripheral calciphylaxis (N = 28) P-value
Gender
Male 33 (68.75%) 13 (65%) 20 (71.43%) 0.636
Female 15 (31.25%) 7 (35%) 8 (28.57%)
Age (years)
<20 0 0 0 0.588
20–40 9 (18.75%) 5 (25%) 4 (14.29%)
40–60 19 (39.58%) 7 (35%) 12 (42.86%)
≥60 20 (41.67%) 8 (40%) 12 (42.86%)
BMI(kg/m 2 )
<18.5 5 (10.42%) 3 (15%) 2 (7.14%) 0.872
18.5–24.0 22 (45.83%) 8 (40%) 14 (50%)
≥24.0 21 (43.75%) 9 (45%) 12 (42.86%)
Duration of dialysis (months) 84.00 (48.00, 138.75) 91.50 (60.00, 143.75) 69.50 (39.00, 133.75) 0.457
History of SHPT
SHPT 35 (72.92%) 15 (75%) 20 (71.43%) 0.784
Duration of SHPT (months) 35.00 (13.00, 72.00) 34.00 (23.00, 72.00) 38.00 (7.00, 67.75) 0.881
Parathyroidectomy 15 (42.86%) 8 (53.33%) 7 (35%) 0.278
Postoperative hypocalcemia 14 (93.33%) 8 (100%) 6 (85.71%) 0.467
Diagnosis of calciphylaxis
More than 2 painful and non-treatable skin ulcers 46 (95.83%) 20 (100%) 26 (92.86%) 0.504
Skin biopsy 34 (70.83%) 9 (45%) 25 (89.29%) 0.001
Arteriole calcification on biopsy 22 (64.71%) 8 (88.89%) 14 (56%) 0.173
Bone scintigraphy 32 (66.67%) 7 (35%) 25 (89.29%) <0.001
Positive result of bone scintigraphy 20 (62.5%) 5 (71.43%) 15 (60%) 0.912